All posts by psufka

Nintedanib for Systemic Sclerosis–Associated ILD

Our next #RheumJC will be Thursday, May 30th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the NEJM article: Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Assessing RA Disease Activity using Digital Technology

Our next #RheumJC will be Thursday, April 25th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the Arthritis Care & Research article: Assessing RA Disease Activity with PROMIS Measures using Digital Technology.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Tramadol and Mortality in Osteoarthritis

Our next #RheumJC will be Thursday, March 28th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the JAMA article: Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis

For some bonus learning, we suggest reading the writeup on the Nephmadness 2019: Pain Region, which includes sections on tramadol as well as opioids, NSAIDs, and GABAnergics.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Ustekinumab in Axial Spondyloarthritis

❄️ Happy February! ☃️

Our next #RheumJC will be Thursday, February 28th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

We’ll be discussing the Arthritis & Rheumatology article: Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Ustekinumab for Lupus

Happy New Year!

Our first #RheumJC of 2019 will be Thursday, January 31st at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

We’ll be discussing the Lancet article: Efficacy and safety of ustekinumab, an IL–12 and IL–23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Favorite Abstracts from #ACR18

The next #RheumJC session will be Thursday, November 15th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

We’ll be discussing four of our favorite abstracts from the ACR 2018 Annual Meeting, chosen by a combination of the #RheumJC team and your responses to our poll.

To cast your vote in our poll, click on this link (poll ends Wed Nov 14): https://twitter.com/RheumJC/status/1061722574533595137

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Biologic Refractory RA

The next #RheumJC session will be Thursday, September 27th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

Based on this months (extremely close) poll, we’ll be doing the ARD BMJ article Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. This article is open access.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Association of Stress with Autoimmune Disease

The next #RheumJC session will be Thursday, August 30th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

This month, as promised, we’re doing the JAMA article Association of Stress-Related Disorders With Subsequent Autoimmune Disease.

While this article is not open access, we’ll certainly be summarizing the article and discussing findings in typical journal club style. We hope you’ll join us and your online colleagues for this learning opportunity.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

MAINRITSAN2: tailored vs fixed-schedule rituximab for ANCA vasculitis remission

The next #RheumJC session will be Thursday, July 26th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

We ran a fun experiment using Twitter polls to decide on this month’s #RheumJC, and in the end it came down to 1 vote (we’ll plan on doing the JAMA stress & autoimmunity article next month).

In the end, we’ll be doing the Annals of the Rheumatic Diseases article: Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

While this article is not open access, we’ll certainly be summarizing the article and discussing findings in typical journal club style. We hope you’ll join us and your online colleagues for this learning opportunity.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

The ACR Workforce Study

Our next #RheumJC session will be Thursday, June 28th at 10pm Eastern Time / 9pm Central Time (click here to find this in your local time zone).

We’ll be discussing the Arthritis & Rheumatology article: 2015 American College of Rheumatology Workforce Study: The Role of Graduate Medical Education in Adult Rheumatology. (Direct link to pdf).

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.